Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2017

View Archived Issues

TREOS Bio raises funds to support clinical trial of colorectal cancer vaccine

Aequus Pharmaceuticals completes dosing in POC trial of AQS-1301

Allergan to acquire ZELTIQ

Viking Therapeutics reaches funding agreement for clinical development of VK-2809

Consortium of private investors acquires NexImmune

Surrozen closes series A financing

X-Chem, Janssen expand inflammatory disease collaboration

Insys Therapeutics provides cannabidiol oral solution for compassionate use studies

Boehringer Ingelheim and Weill Cornell Medicine enter COPD collaboration

FDA approves Siliq for plaque psoriasis

Phase III data show non-inferiority of doravirine and darunavir/ritonavir

Parsabiv launched in Japan

NCI grant supports breast cancer ADC research at Scripps Research Institute

Promising phase III results of UX-003 in patients with MPS VII

Clinical data reported for Fabry's disease candidate lucerastat

Chong Kun Dang Holdings divulges novel HDAC6 inhibitors

Hetero Research Foundation patents antiviral agents

Nanchang Helioeast identifies novel JAK inhibitors

ALK seeks European approval for ragweed sublingual allergy immunotherapy

Laboratorio Farmaceutico CT Srl patents ROS production inhibitors

Taiho Pharmaceutical discovers JAK3 inhibitors

Vedanta Biosciences collaborates with Stanford University and Leiden University

Roche discloses new mGlu4 receptor positive allosteric modulators

Amunix Operating enters R&D collaboration with Genentech

Tapimmune's phase II study of TPIV-200 in TNBC cleared to continue

Cytori Therapeutics completes acquisition of Azaya Therapeutics

Daiichi Sankyo conducts Japanese phase I trial of DS-1001b in IDH1 mutated gliomas

Daiichi Sankyo's DS-3032b receives U.S. orphan designation for liposarcoma

New mouse model of Staphylococcus aureus vascular graft infection developed

FDA designates Nuedexta an orphan drug for amyotrophic lateral sclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.